Approval · Notice of Compliance 7237 · 2005
LITHANE: Notice of Compliance 7237
Issued July 12, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7237
- Date
- July 12, 2005
- Company
- Erfa Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antimanic agent
Products in this notice
Medicinal ingredients
- LITHIUM CARBONATE 150 MG per CAP
- LITHIUM CARBONATE 300 MG per CAP